| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulgent Genetics, Inc. (FLGT) has 4 insiders with recent SEC Form 4 filings, including 13 buys and 3 sells. FLGT is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 951.6K | $17.16M | - | |
| CEO | 897.7K | $16.19M | - | |
| COO | 332.0K | $5.99M | - | |
| CFO | 328.1K | $5.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2018 | Kim Paul77 | CFO And Treasurer | Sell | 1,628 | $3.76 | $6,121.28 | -0.4% | |
| Nov 30, 2017 | Hsieh Ming | President And CEO | Buy | 2,000 | $3.60 | $7,208.40 | New | |
| Nov 21, 2017 | Hsieh Ming | President And CEO | Buy | 1,599 | $3.13 | $4,997.35 | - | |
| Nov 20, 2017 | Hsieh Ming | President And CEO | Buy | 19,550 | $3.21 | $62,667.57 | +0.1% | |
| Nov 16, 2017 | Hsieh Ming | President And CEO | Buy | 2,205 | $3.23 | $7,121.38 | - | |
| Nov 14, 2017 | Hsieh Ming | President And CEO | Buy | 10,504 | $3.30 | $34,642.54 | - | |
| Nov 13, 2017 | Kim Paul77 | CFO And Treasurer | Sell | 1,573 | $3.22 | $5,065.06 | -0.4% | |
| Nov 10, 2017 | Hsieh Ming | President And CEO | Buy | 20,905 | $3.42 | $71,431.69 | +0.2% | |
| Aug 11, 2017 | Kim Paul77 | CFO And Treasurer | Sell | 6,134 | $5.71 | $35,016.55 | -1.6% | |
| Jun 15, 2017 | Hsieh Ming | President And CEO | Buy | 20,000 | $5.26 | $105,228.45 | +0.2% |